This article describes the identification and characterization of 2-(2-(4-chlorophenyl)acetamido)-3-methylbutanamide, a putative new psychoactive substance, through GC/MS, LC/MS, NMR, FTIR, UV, Single-crystal X-ray diffraction, and NMR.
Research
Tags
2C-B 2C-X alcohol alprazolam amphetamine anxiety benzodiacepine bipolar buprenorphine bupropion cannabis cocaine depression DMT drug checking service drug testing ecstasy fentanyl GBL GHB heroin isotretinoin ketamine lidocaine LSD MDMA memory mephedrone methadone methamphetamine methylone methylphenidate morphine mushroom NBOME NPS opiates opium oxandrolone oxycodone schizophrenia speed steroids testosterone tramadol
Recent posts
- Changes to how/when we quantify some substances 12 January, 2020
- Back from the holidays 10 January, 2020
- Etizolam Quantification Available 10 July, 2019
- Delay in some results in our International Drug Checking Service 6 May, 2019
- ALERT: Update on adulterated samples of ALPRAZOLAM 6 April, 2019
- Use and abuse of Drug Checking by cryptomarkets vendors 25 February, 2019